Cancer

COSELA® (Trilaciclib Hydrochloride for Injection) Now Approved in China to Decrease the Incidence of Chemotherapy-Induced Myelosuppression in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Staff July 13, 2022

RESEARCH TRIANGLE PARK, N.C., July 13, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today...

First Patient Enrolled in the Streamlined Localization (STREAMLoc) Registry Study Using SCOUT® at Biopsy in Canada

Staff July 13, 2022

Prospective, observational study to assess the clinical utility of the SCOUT® Radar Localization System (SCOUT) in real-world practiceSOUTH JORDAN, Utah,...

CureVac Presents Promising Data at SITC from Phase 1 Study of Oncology Candidate CV8102 Showing Systemic Immune Response

user November 10, 2021

∙ Immune profiling of clinical trial participants in Phase 1 dose-escalation study shows immune response in both injected and non-injected...

CureVac Expands Lead RNA Cancer Program Phase 1 Trial in Advanced Melanoma

user February 4, 2021

CV8102 recommended dose identified; expansion trial to confirm safety, tolerability, and efficacy Trial expansion focuses on advanced melanoma, an indication of...

4 Ways Research and Treatment of Cancer are Changing Due to Blockchain Technology

user August 24, 2020

Blockchain technology was originally designed to facilitate the safe transfer and storage of bitcoin, the world’s first and most popular...

Immunomedics In Software Project With Ideagen To Streamline Document Reviews Of Cancer Treatment Processes

user November 7, 2019

Ideagen’s PleaseReview will improve review, co-authoring and redaction projects linked to cancer and other oncology treatments US-based pharmaceutical company, Immunomedics, is...

Cancer

COSELA® (Trilaciclib Hydrochloride for Injection) Now Approved in China to Decrease the Incidence of Chemotherapy-Induced Myelosuppression in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

First Patient Enrolled in the Streamlined Localization (STREAMLoc) Registry Study Using SCOUT® at Biopsy in Canada

CureVac Presents Promising Data at SITC from Phase 1 Study of Oncology Candidate CV8102 Showing Systemic Immune Response

CureVac Expands Lead RNA Cancer Program Phase 1 Trial in Advanced Melanoma

4 Ways Research and Treatment of Cancer are Changing Due to Blockchain Technology

Immunomedics In Software Project With Ideagen To Streamline Document Reviews Of Cancer Treatment Processes

After Trump’s Marijuana Executive Order, Will the DEA Face a Court Imposed Deadline from MMJ’s Writ of Mandamus?

Black Book Research Releases Its 2026 Annual Methodology and Governance Statement for Healthcare IT Vendor Rankings

Black Book Research Releases Its 2026 Annual Methodology and Governance Statement for Healthcare IT Vendor Rankings

Awake Breast Augmentation: Gruber Plastic Surgery Highlights Live Implant Sizing Under Local Anesthesia With No Sedation for Eligible Patients

Clemson University and Nordic Wellness Launch Groundbreaking Partnership to Transform the Student Mental Health Crisis

You may have missed